Keros Therapeutics, Inc. Common Stock
NASDAQ · KROS
Fundamentals
Market cap
$202.07M
Price / Earnings ratio
-2.4x
Price / Sales ratio
6.1x
Price / Book ratio
0.7x
Return on assets
-0.2%
Ex-Dividend date
N/A
Last payment date
N/A
Dividend amount
$0.00
Dividend yield
0.0%
Debt / Equity ratio
N/A


